Actively Recruiting
Health-Related Quality of Life and Metabolic Outcomes in PCOS
Led by The Cleveland Clinic · Updated on 2026-05-06
40
Participants Needed
1
Research Sites
83 weeks
Total Duration
On this page
Sponsors
T
The Cleveland Clinic
Lead Sponsor
A
American Academy of Family Physicians
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary outcome of interest is change in PCOS health-related quality of life, while the secondary outcome of interest is change in adiposity, cardiometabolic, and inflammation biomarkers.
CONDITIONS
Official Title
Health-Related Quality of Life and Metabolic Outcomes in PCOS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-pregnant females ages 18 to 49 years
- Preexisting diagnoses of PCOS and obesity (BMI equal or greater to 30 kg/m2) at enrollment
You will not qualify if you...
- Pregnant or planning to become pregnant during the study period
- Current or recent participation (less than 12 months) in a PCOS-focused group
- Documented monogenic obesity
- Diagnosis of any type of diabetes except prediabetes
- Use of systemic glucocorticoid therapy for more than 7 days at enrollment
- End-stage organ disease
- Lack of internet access
- Need for English language interpretation
- Any condition that would prevent completing the study according to medical judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Actively Recruiting
Research Team
A
Andrea Parianos
CONTACT
A
Amber Sike
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here